Blog
Newsletter
Victory at the FDA
I wrote a post about the FDA committee hearing about the risks of fluoroquinolones for Hormones Matter. Here it is: Victory at the FDA for Fluoroquinolone Victims As Chandler Marrs noted when she posted it on Facebook (BTW, shares are appreciated!): "Who's to...
FDA Hearing – Victory for Victims of Fluoroquinolones
On November 5, 2015, a meeting was held at the FDA's White Oak campus in Silver Spring, Maryland, for the Antimicrobial Drugs Advisory Committee to discuss, "the risks and benefits of the systemic fluoroquinolone antibacterial drugs for the treatment of acute...
The Hardest Topic – Suicide
People who are in pain, and depressed, and desperate for help, and who have had everything that they cherish taken away from them--their health, their mental health, their job, their family, their money, their stability, and more--often reach out to me. I am happy to...
Is Fluoroquinolone Toxicity “Real?”
What is required for fluoroquinolone toxicity to be “real?” Most of the symptoms of fluoroquinolone toxicity are listed on the warning labels. Tendinitis? Yup, listed on the warning label. Muscle weakness? Yup, that’s there too. Cardiovascular collapse, loss of...
An Official Name: Fluoroquinolone-Associated Disability (FQAD)
For the FDA’s November 5, 2015 meeting to review “The Benefits and Risks of Systemic Fluoroquinolone Antibacterial Drugs for the Treatment of Acute Bacterial Sinusitis (ABS), Acute Bacterial Exacerbation of Chronic Bronchitis in Patients Who Have Chronic Obstructive...
The FDA Notes that Fluoroquinolones are no Better than Placebos
For the FDA's November 5, 2015 meeting to review “The Benefits and Risks of Systemic Fluoroquinolone Antibacterial Drugs for the Treatment of Acute Bacterial Sinusitis (ABS), Acute Bacterial Exacerbation of Chronic Bronchitis in Patients Who Have Chronic Obstructive...